IL17A and psoriasis: For instance, paradoxical Behçet’s disease—characterized by recurrent oral and genital ulcers—has been reported in patients undergoing treatment with IL-17A inhibitors like ixekizumab and secukinumab for psoriasis or other immune-mediated diseases [27,28].